tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

PHAR Stock Latest News

Pharming Group Expands Stake in Abliva to 92.70%
Company AnnouncementsPharming Group Expands Stake in Abliva to 92.70%
19d ago
6K
PHAR
Pharming to nominate Fabrice Chouraqui as new CEO, succeeding Sijmen de Vries
PremiumThe Fly
Pharming to nominate Fabrice Chouraqui as new CEO, succeeding Sijmen de Vries
2M ago
PHAR
Pharming Group price target raised to EUR 2.15 from EUR 1.60 at RBC Capital
PremiumThe Fly
Pharming Group price target raised to EUR 2.15 from EUR 1.60 at RBC Capital
3M ago
PHAR
H.C. Wainwright calls Pharming ‘nice stocking stuffer’ after deal
PremiumThe Fly
H.C. Wainwright calls Pharming ‘nice stocking stuffer’ after deal
3M ago
PHAR
Pharming announces public cash offer to shareholders of Abliva AB
PremiumThe Fly
Pharming announces public cash offer to shareholders of Abliva AB
3M ago
PHAR
Pharming initiated with a Buy at Jefferies
PremiumThe FlyPharming initiated with a Buy at Jefferies
3M ago
PHAR
Pharming price target lowered to EUR 1.60 from EUR 1.65 at RBC Capital
Premium
The Fly
Pharming price target lowered to EUR 1.60 from EUR 1.65 at RBC Capital
4M ago
PHAR
Pharming price target lowered to $30 from $31 at Oppenheimer
Premium
The Fly
Pharming price target lowered to $30 from $31 at Oppenheimer
4M ago
PHAR
Is PHAR a Buy, Before Earnings?
PremiumPre-Earnings
Is PHAR a Buy, Before Earnings?
5M ago
PHAR
Pharming Group Delays Leniolisib EU Approval
PremiumCompany Announcements
Pharming Group Delays Leniolisib EU Approval
10M ago
6K
PHAR
Pharming Group Shareholders Approve Key Proposals
PremiumCompany Announcements
Pharming Group Shareholders Approve Key Proposals
10M ago
6K
PHAR
Pharming Group Announces Convertible Bonds Redemption
PremiumCompany Announcements
Pharming Group Announces Convertible Bonds Redemption
10M ago
6K
PHAR
Pharming Group Boasts Strong Q1 Revenue Growth
PremiumCompany AnnouncementsPharming Group Boasts Strong Q1 Revenue Growth
10M ago
6K
PHAR
Pharming Group’s Strategic Financial Maneuver
Premium
Company Announcements
Pharming Group’s Strategic Financial Maneuver
11M ago
6K
PHAR
Pharming Group Lauded for Rare Disease Treatment
Premium
Company Announcements
Pharming Group Lauded for Rare Disease Treatment
11M ago
6K
PHAR
Pharming Completes Trial Enrollment for Pediatric Drug
PremiumCompany Announcements
Pharming Completes Trial Enrollment for Pediatric Drug
11M ago
6K
PHAR
Joenja’s Journey: Navigating the Market Risks and Regulatory Challenges Post-Approval for Pharming Group Nv
PremiumCompany Announcements
Joenja’s Journey: Navigating the Market Risks and Regulatory Challenges Post-Approval for Pharming Group Nv
11M ago
PHAR
Pharming Group Files Annual Report, Sets AGM Date
PremiumCompany Announcements
Pharming Group Files Annual Report, Sets AGM Date
11M ago
6K
PHAR
Pharming Group price target raised to EUR 1.85 from EUR 1.75 at RBC Capital
PremiumThe Fly
Pharming Group price target raised to EUR 1.85 from EUR 1.75 at RBC Capital
12M ago
PHAR
PHAR Earnings this Week: How Will it Perform?
PremiumPre-EarningsPHAR Earnings this Week: How Will it Perform?
12M ago
PHAR
Pharming Group price target lowered to EUR 1.75 from EUR 2.10 at RBC Capital
Premium
The Fly
Pharming Group price target lowered to EUR 1.75 from EUR 2.10 at RBC Capital
1y ago
PHAR
Pharming management to meet with Oppenheimer
Premium
The Fly
Pharming management to meet with Oppenheimer
1y ago
PHAR

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >